Unknown

Dataset Information

0

Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism.


ABSTRACT: BACKGROUND: Bone morphogenetic protein receptor II (BMPR-II) plays an important role in tumor's invasion and proliferation. In this study, we observed the effects of small interfering RNA (siRNA) targeting bone morphogenetic protein receptor II (BMPR-II) on the biological activities of human liver cells and explore its mechanism. METHODS: The molecular sequences of three siRNA targeting BMPR-IIwere designed and synthesized. In this study, there were 6 groups including group I (normal control), group II (blank control), group III (negative control) and group IV-VI (BMPR-II-siRNA-a, siRNA-b and siRNA-c-transfected cells, respectively). The levels of mRNA and protein of BMPR-II were determined to select the best sequence for BMPR-II silence. After liver cancer cells were transfected with the best sequence, proliferation and invasion of transfected cells were assessed, and apoptosis and cell cycle were detected. The expressions of mitogen-activated protein kinases (MAPKs) signal pathway-related VEGF-C protein were observed after BMPR-II silence and BMPR-II silence combined with inhibiting MAPKs signal pathway, respectively. RESULTS: RT-PCR and Western blot indicated that BMPR-II expression was the highest in HepG2 among the three liver cancer lines (P < 0.01) and the lowest in group IV among the six groups (P < 0.01). MTT assay and transwell assay revealed that the numbers of cell growth and cell transmembrane were significantly lower in group IV than in control groups 48 h after cells were transfected (P < 0.05). Flow cytometer showed that apoptosis was the highest and cells were significantly blocked in S phase 48 h after cells were transfected in group IV (P < 0.01). Western blot indicated that the protein levels of p-P38 (P < 0.01) and vascular endothelial growth factor-C (VEGF-C) (P < 0.01) were significantly decreased after BMPR-II silence. The protein level of VEGF-C was significantly decreased in PD98059 + siRNA-BMPR-II-a and SB203580 + siRNA-BMPR-II-a groups (P < 0.01), especially in SB203580 + siRNA-BMPR-II-a group (P < 0.01). CONCLUSIONS: siRNA targeting BMPR-IIcan markedly inhibit HepG2 proliferation and invasion, promote apoptosis and block HepG2 in S phase. Its mechanism may be that BMPR-II silence down-regulates VEGF-C expression through MAPK/P38 and MAPK/ERK1/2 pathways, especially MAPK/P38. This study provides a new targeted therapy for liver cancer.

SUBMITTER: Zeng P 

PROVIDER: S-EPMC4083141 | biostudies-other | 2014

REPOSITORIES: biostudies-other

altmetric image

Publications

Effects of siRNA targeting BMPR-II on the biological activities of human liver cancer cells and its mechanism.

Zeng Peng P   Cai Sheng S   Zhang Jia-Na JN   Yi Feng-Ming FM   Jiang Wei-Min WM   Wu Jian-Bing JB  

Cancer cell international 20140619


<h4>Background</h4>Bone morphogenetic protein receptor II (BMPR-II) plays an important role in tumor's invasion and proliferation. In this study, we observed the effects of small interfering RNA (siRNA) targeting bone morphogenetic protein receptor II (BMPR-II) on the biological activities of human liver cells and explore its mechanism.<h4>Methods</h4>The molecular sequences of three siRNA targeting BMPR-IIwere designed and synthesized. In this study, there were 6 groups including group I (norma  ...[more]

Similar Datasets

| S-ECPF-GEOD-55503 | biostudies-other
| S-EPMC4049674 | biostudies-literature
2015-03-01 | E-GEOD-55503 | biostudies-arrayexpress
2015-03-01 | GSE55503 | GEO
| S-EPMC9023565 | biostudies-literature
| S-EPMC6996342 | biostudies-literature
| S-EPMC2475506 | biostudies-literature
| S-EPMC8795958 | biostudies-literature
| S-EPMC7356887 | biostudies-literature
| S-EPMC8630440 | biostudies-literature